Cargando…
Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
As regulators of malignant cell behaviour and communication with stroma, cytokines have proved useful in understanding cancer biology and developing novel therapies. In renal cell carcinoma, patients with inflammatory reactions are known to have poor prognosis. In order to elucidate the relation bet...
Autores principales: | Yoshida, N, Ikemoto, S, Narita, K, Sugimura, K, Wada, S, Yasumoto, R, Kishimoto, T, Nakatani, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375361/ https://www.ncbi.nlm.nih.gov/pubmed/11986770 http://dx.doi.org/10.1038/sj.bjc.6600257 |
Ejemplares similares
-
Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019) -
Pretreatment serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α levels predict the progression of colorectal cancer
por: Chang, Pei‐Hung, et al.
Publicado: (2016) -
Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis
por: Perry, M G, et al.
Publicado: (2009) -
Tumour Necrosis Factor-Α, Interleukin-1 and Interleukin-6 Serum Levels and Its Correlation with Pain Severity in Chronic Tension-Type Headache Patients: Analysing Effect of Dexketoprofen Administration
por: Rambe, Aldy Safruddin, et al.
Publicado: (2017) -
Can Tumor Necrosis Factor-α and Interleukin-6 Be Used as Prognostic Markers of Infection following Ureteroscopic Lithotripsy?
por: Bantis, Athanasios, et al.
Publicado: (2014)